Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Halberd Corporation < Previous 1 2 Next > Halberd's PTSD/Alzheimer's R&D Reveals Link to Potential Obesity Cure October 20, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd and GTX Corp. Sign Scientific Collaboration and Reseller Agreement October 12, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers GTXO HALB Halberd Corporation CEO Letter October 07, 2021 From Halberd Corporation Via AccessWire Topics Death Intellectual Property Regulatory Compliance Exposures COVID-19 Death Intellectual Property Tickers HALB Halberd's VITASHIELDMAX(TM) Immunity Support Product Available on Amazon October 05, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd and heliosDX of RushNet Enter Scientific Collaboration Agreement September 22, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB RSHN Halberd's Treatment Eradicates Primary Building Block of Alzheimer’s Disease September 13, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Corporation Appoints Anthony Mirabelli Vice-President, Mergers & Acquisitions September 08, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Corporation Alzheimer's Disease Treatment Tests Yield Outstanding Results August 30, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Receives Patent for Treatment of Cockayne Syndrome - May Provide Pathway to Slow Aging August 25, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Files Provisional Patent Application - Furthering Efforts on Alzheimer's Disease August 23, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Tickers HALB Halberd Corp. VITA-SHIELD-MAX(TM) Available - Buy Now! August 18, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd’s Disease Elimination Technology R&D at Youngstown State University (YSU) Draws Attention of CBS Affiliate WKBN August 16, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Corporation Adds Blood-Borne Disease Treatment Capability With Addition Of Noted Nephrologist August 11, 2021 From Halberd Corporation Via AccessWire Topics Death Intellectual Property Regulatory Compliance Exposures COVID-19 Death Intellectual Property Tickers HALB Halberd Corporation's VITA-SHIELD-MAX(TM) Immunity Support Product Shipped August 09, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Corporation Successfully Establishes Disease Eradication Proof-of-Concept - "Never Before Accomplished" July 28, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Tickers HALB Halberd Corp. Advances the Elimination of Antigens Present in Alzheimer’s Disease & PTSD/Chronic Traumatic Encephalopathy July 22, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Tickers HALB Halberd Corporation CEO Letter July 06, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Exposures COVID-19 Intellectual Property Tickers HALB Halberd Corp. Discovers a Proprietary Disease-Causing Antigen Removal Process June 30, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Corporation's Proprietary Technology for Alzheimer’s Disease Enters Stage 4 of 7 Stage Process June 21, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Corporation Successfully Conjugates Metallic Particles and Antibodies Against Alzheimer's Disease-Associated Antigens June 16, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Corporation Undertakes Process Toward the Elimination of Alzheimer’s Disease June 09, 2021 From Halberd Corporation Via AccessWire Topics Death Intellectual Property Regulatory Compliance Exposures COVID-19 Death Intellectual Property Tickers HALB Halberd Corporation Creates Two New and Stronger SARS-CoV-2 Neutralizing Antibodies June 07, 2021 From Halberd Corporation Via AccessWire Topics Animal Testing Intellectual Property Regulatory Compliance Exposures Animal Testing COVID-19 Intellectual Property Tickers HALB Halberd Corp. Files Provisional Patent Application Complementing Patented Extracorporeal Radio Frequency/Laser Projects June 01, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Corporation Successfully Conjugates Metallic Particles and E. Coli Antibody May 25, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB "MarketWatch" Features Halberd Corporation With Prominent Pharmaceutical Companies on New Treatments for COVID-19 May 19, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Corporation Reports Successful Conjugation of Metallic Particles & SARS-CoV-2 Proprietary Monoclonal Antibody May 17, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Corporation Begins Testing of Patented Process for Laser Eradication of Disease May 13, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Corp. Designated as a BREAKOUT Stock to Watch in Investor Publications May 10, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Corporation Appoints New Chief Technical Officer to Optimize Upcoming Experiments On Radio Frequency and Laser Eradication of Disease May 04, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB Halberd Corporation Files International Patent Cooperation Treaty (PCT) Application on Treating and Curing Covid-19 Infection Utilizing a Laser April 26, 2021 From Halberd Corporation Via AccessWire Topics Intellectual Property Regulatory Compliance Exposures COVID-19 Intellectual Property Legal Tickers HALB < Previous 1 2 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.